Akebia Therapeutics, Inc. (FRA:AX9)
1.339
+0.043 (3.32%)
At close: Dec 5, 2025
Akebia Therapeutics Market Cap
Akebia Therapeutics has a market cap or net worth of €351.29 million as of December 5, 2025. Its market cap has decreased by -6.33% in one year.
Market Cap
351.29M
Enterprise Value
379.28M
Revenue
191.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.34
Market Cap Chart
Since March 21, 2014, Akebia Therapeutics's market cap has increased from 331.28M to 351.29M, an increase of 6.04%. That is a compound annual growth rate of 0.50%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 248.18B |
| Siemens Aktiengesellschaft | 179.36B |
| Allianz SE | 139.43B |
| Deutsche Telekom AG | 131.24B |
| Siemens Energy AG | 99.98B |
| Rheinmetall AG | 70.18B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 68.26B |
| Deutsche Bank Aktiengesellschaft | 59.33B |